Macleods Pharmaceuticals Ltd — Ciprofloxacin Exporter Profile
Indian Pharmaceutical Exporter · #4 for Ciprofloxacin · $1.5M export value · DGFT Verified
Macleods Pharmaceuticals Ltd is the #4 Indian exporter of Ciprofloxacin with $1.5M in export value and 30 verified shipments. Macleods Pharmaceuticals Ltd holds a 0.5% market share in Ciprofloxacin exports across 8 countries.
Macleods Pharmaceuticals Ltd — Ciprofloxacin Export Profile: Buyers & Destinations
Where Does Macleods Pharmaceuticals Ltd Export Ciprofloxacin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| VIETNAM, DEMOCRATIC REP. OF | $314.4K | 7 | 49.9% |
| VIETNAM | $200.0K | 4 | 31.8% |
| ISRAEL | $28.3K | 2 | 4.5% |
| PAKISTAN | $27.4K | 2 | 4.4% |
| JORDAN | $24.7K | 6 | 3.9% |
| FRANCE | $19.0K | 9 | 3.0% |
| BURUNDI | $11.3K | 1 | 1.8% |
| SYRIA | $1.7K | 3 | 0.3% |
| MAURITIUS | $1.5K | 4 | 0.2% |
| LEBANON | $1.2K | 1 | 0.2% |
Macleods Pharmaceuticals Ltd exports Ciprofloxacin to 10 countries. The largest destination is VIETNAM, DEMOCRATIC REP. OF accounting for 49.9% of Macleods Pharmaceuticals Ltd's Ciprofloxacin shipments, followed by VIETNAM (31.8%) and ISRAEL (4.5%). These destinations reflect Macleods Pharmaceuticals Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ciprofloxacin from Macleods Pharmaceuticals Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| DELTA IMPORT - EXPORT MEDICAL CO, | VIETNAM, DEMOCRATIC REP. OF | $200.0K | 4 |
| CAMEL INTERNATIONAL IM -EXPORT CO. | VIETNAM | $150.0K | 3 |
| DELTA IMPORT - EXPORT MEDICAL CO., | VIETNAM, DEMOCRATIC REP. OF | $114.4K | 3 |
| DELTA IMPORT - EXPORT MEDICAL CO | VIETNAM | $50.0K | 1 |
| UNRWA GAZA FIELD OFFICE | ISRAEL | $28.3K | 2 |
| ZUHOOR ELHAM LTD | PAKISTAN | $27.4K | 2 |
| UNRWA HQA PROCUREMENT & LOGISTICS D | JORDAN | $19.8K | 5 |
| PLANETPHARMA | FRANCE | $19.0K | 9 |
| CENTRALE D ACHAT DE MEDICAMENTS (CA | BURUNDI | $11.3K | 1 |
| JORDAN HASHEMITE CHARITY ORGANIZATI | JORDAN | $4.9K | 1 |
Macleods Pharmaceuticals Ltd supplies Ciprofloxacin to 15 buyers globally. The largest buyer is DELTA IMPORT - EXPORT MEDICAL CO, (VIETNAM, DEMOCRATIC REP. OF), followed by CAMEL INTERNATIONAL IM -EXPORT CO. (VIETNAM) and DELTA IMPORT - EXPORT MEDICAL CO., (VIETNAM, DEMOCRATIC REP. OF). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ciprofloxacin Export Value and How Much Does Macleods Pharmaceuticals Ltd Contribute?
India exported $74.6M worth of Ciprofloxacin through 14,146 shipments from 1001 suppliers to 180 countries, serving 3,081 buyers globally. Macleods Pharmaceuticals Ltd contributes $1.5M to this total, accounting for 0.5% of India's Ciprofloxacin exports. Macleods Pharmaceuticals Ltd ships Ciprofloxacin to 10 countries through 15 buyers.
What Is the Average Shipment Value for Macleods Pharmaceuticals Ltd's Ciprofloxacin Exports?
Macleods Pharmaceuticals Ltd's average Ciprofloxacin shipment value is $50.0K per consignment, based on 30 shipments totaling $1.5M. The largest destination is VIETNAM, DEMOCRATIC REP. OF (49.9% of Macleods Pharmaceuticals Ltd's Ciprofloxacin exports).
How Does Macleods Pharmaceuticals Ltd Compare to Other Indian Ciprofloxacin Exporters?
Macleods Pharmaceuticals Ltd ranks #4 among 1001 Indian Ciprofloxacin exporters with a 0.5% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($20.4M), AUROBINDO PHARMA LTD ($11.4M), SENTISS PHARMA PRIVATE LIMITED ($8.8M). Macleods Pharmaceuticals Ltd processed 30 shipments to 8 destination countries.
What Ciprofloxacin Formulations Does Macleods Pharmaceuticals Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CIPROFLOXACIN TABLETS USP 500 MG 10X10 (49642 PAC) | $150.0K | 3 |
| CIPROFLOXACIN 500 MG TABLETS 10X10S (49757 PAC) | $114.4K | 3 |
| CIPROFLOXACIN 500 MG TABLETS 10X10S (44 | $100.0K | 2 |
| CIPROFLOXACIN 500 MG TABLETS 10X10S (55 | $50.0K | 1 |
| CIPROFLOXACIN TABLETS USP 500 MG 10X10S | $50.0K | 1 |
| CIPROFLOXACIN 500 MG TABLETS 10X10S (49764 PAC) | $50.0K | 1 |
| CIPROFLOXACIN (AS HYDROCHLORIDE) 500 MG | $28.3K | 2 |
| CIPROFLOXACIN 500 MG TABLETS 10X10S (18 | $16.9K | 4 |
| CIPROMAC 500MG TABLETS(CIPROFLOXACIN TABLETS USP 500 MG) 1X10S 5070 PAC | $15.2K | 1 |
| CIPROMAC 750 (CIPROFLOXACIN TABLETS 750MG)- 1X10S 3048 PAC | $12.2K | 1 |
Macleods Pharmaceuticals Ltd exports 23 distinct Ciprofloxacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CIPROFLOXACIN TABLETS USP 500 MG 10X10 (49642 PAC) with 3 shipments worth $150.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Macleods Pharmaceuticals Ltd Compare to Nearest Ciprofloxacin Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 14 | BRAWN LABORATORIES LIMITED | $3.4M | 67 | 12 | $50.0K |
| 1 | DR.REDDY'S LABORATORIES LTD | $2.7M | 54 | 3 | $50.0K |
| 4 | MACLEODS PHARMACEUTICALS LTD ★ | $1.5M | 30 | 8 | $50.0K |
| 10 | MEDNEXT BIOTECH LIMITED | $1.3M | 25 | 4 | $50.0K |
| 3 | DR REDDYS LABORATORIES LIMITED | $1.1M | 22 | 1 | $50.0K |
Macleods Pharmaceuticals Ltd ranks #4 among 1001 Indian Ciprofloxacin exporters. Average shipment value of $50.0K compared to the market average of $74.5K. The closest competitors by value are BRAWN LABORATORIES LIMITED and DR.REDDY'S LABORATORIES LTD.
Which Indian Ports Ship Ciprofloxacin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 1,828 | 12.9% |
| SAHAR AIR | 1,481 | 10.5% |
| NHAVA SHEVA SEA (INNSA1) | 1,254 | 8.9% |
| DELHI AIR CARGO ACC (INDEL4) | 969 | 6.8% |
| JNPT/ NHAVA SHEVA SEA | 766 | 5.4% |
| DELHI AIR | 722 | 5.1% |
| JNPT | 595 | 4.2% |
| Bombay Air | 375 | 2.7% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ciprofloxacin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ciprofloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Macleods Pharmaceuticals Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 39 individual customs records matching Macleods Pharmaceuticals Ltd exporting Ciprofloxacin, covering 23 formulations to 10 countries via 15 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 180+ countries, 3,081+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ciprofloxacin Export Data from Macleods Pharmaceuticals Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Macleods Pharmaceuticals Ltd's Ciprofloxacin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Macleods Pharmaceuticals Ltd
Company Profile
0 products · $0 total trade · 0 categories
Ciprofloxacin Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Macleods Pharmaceuticals Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ciprofloxacin. For current shipment-level data, contact TransData Nexus.